Shinichi Hirakawa
Papers
1
Total Citations
18
H-Index
1
About
Shinichi Hirakawa is a pioneering figure in molecular diagnostics, whose work has fundamentally advanced the field of viral nucleic acid detection. His primary research focuses on the development and automation of high-throughput systems for identifying blood-borne pathogens, most notably hepatitis B virus (HBV) and hepatitis C virus (HCV). Hirakawa’s major contribution lies in his innovative integration of robotic nucleic acid purification with real-time PCR technology, a methodological breakthrough that dramatically increased the speed, accuracy, and scalability of viral screening. His landmark 2002 study, cited 18 times, demonstrated the first successful combination of a BioRobot 9604 with real-time detection PCR on the PRISM 7700 system, creating a fully automated pipeline capable of processing large sample volumes. This work was directly applied to the critical analysis of posttransfusion hepatitis, providing a robust solution for ensuring blood supply safety. By eliminating manual extraction bottlenecks and reducing contamination risks, Hirakawa’s system set a new standard for clinical virology laboratories. His achievements have had a lasting impact on transfusion medicine, enabling faster, more reliable detection of HBV DNA and HCV RNA, and ultimately saving lives through improved diagnostic precision.
Research Focus
Key Achievements
Top Papers
- 1